Teva Pharmaceutical (Israel) Risk Analysis And Volatility Evaluation

TEVA -- Israel Stock  

ILS 7,940  98.00  1.22%

Macroaxis considers Teva Pharmaceutical to be not too risky. Teva Pharmaceutical owns Efficiency Ratio (i.e. Sharpe Ratio) of -0.2904 which indicates Teva Pharmaceutical had -0.2904% of return per unit of risk over the last 1 month. Macroaxis philosophy towards measuring risk of any stock is to look at both systematic and un-systematic factors of the business, including all available market data and technical indicators. Teva Pharmaceutical Industries Limited exposes twenty-one different technical indicators which can help you to evaluate volatility that cannot be diversified away. Please be advised to validate Teva Pharmaceutical Coefficient Of Variation of 7,197 and Risk Adjusted Performance of 0.009173 to confirm risk estimate we provide.
Horizon     30 Days    Login   to change

Teva Pharmaceutical Market Sensitivity

As returns on market increase, returns on owning Teva Pharmaceutical are expected to decrease at a much smaller rate. During bear market, Teva Pharmaceutical is likely to outperform the market.
One Month Beta |Analyze Teva Pharmaceutical Demand Trend
Check current 30 days Teva Pharmaceutical correlation with market (DOW)
β = -0.2039
Teva Pharmaceutical Almost negative betaTeva Pharmaceutical Beta Legend

Teva Pharmaceutical Technical Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of seventeen. Teva Pharmaceutical Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input. View also all equity analysis or get more info about average price price transform indicator.

Teva Pharmaceutical Projected Return Density Against Market

Assuming 30 trading days horizon, Teva Pharmaceutical Industries Limited has beta of -0.2039 . This entails as returns on benchmark increase, returns on holding Teva Pharmaceutical are expected to decrease at a much smaller rate. During bear market, however, Teva Pharmaceutical Industries Limited is likely to outperform the market. Additionally, Teva Pharmaceutical Industries Limited has a negative alpha implying that the risk taken by holding this equity is not justified. The company is significantly underperforming DOW
 Predicted Return Density 
      Returns 
Assuming 30 trading days horizon, the coefficient of variation of Teva Pharmaceutical is -344.3. The daily returns are destributed with a variance of 4.47 and standard deviation of 2.11. The mean deviation of Teva Pharmaceutical Industries Limited is currently at 1.55. For similar time horizon, the selected benchmark (DOW) has volatility of 1.09
α
Alpha over DOW
=0.08
β
Beta against DOW=0.2
σ
Overall volatility
=2.11
Ir
Information ratio =0.0468

Teva Pharmaceutical Return Volatility

Teva Pharmaceutical Industries Limited accepts 2.1137% volatility on return distribution over the 30 days horizon. DOW inherits 1.0635% risk (volatility on return distribution) over the 30 days horizon.
 Performance (%) 
      Timeline 

Market Risk Breakdown

Teva Pharmaceutical Volatility Factors

30 Days Market Risk

Not too risky

Chance of Distress in 24 months

Almost imposible

30 Days Economic Sensitivity

Moves indifferently to market move

Investment Outlook

Teva Pharmaceutical Investment Opportunity

Teva Pharmaceutical Industries Limited has a volatility of 2.11 and is 1.99 times more volatile than DOW. 19% of all equities and portfolios are less risky than Teva Pharmaceutical. Compared to the overall equity markets, volatility of historical daily returns of Teva Pharmaceutical Industries Limited is lower than 19 (%) of all global equities and portfolios over the last 30 days. Use Teva Pharmaceutical Industries Limited to protect against small markets fluctuations. The stock experiences somewhat bearish sentiment, but market may correct it shortly. Check odds of Teva Pharmaceutical to be traded at S7701.8 in 30 days. As returns on market increase, returns on owning Teva Pharmaceutical are expected to decrease at a much smaller rate. During bear market, Teva Pharmaceutical is likely to outperform the market.

Teva Pharmaceutical correlation with market

Good diversification
Overlapping area represents the amount of risk that can be diversified away by holding Teva Pharmaceutical Industries and equity matching DJI index in the same portfolio.

Teva Pharmaceutical Volatility Indicators

Teva Pharmaceutical Industries Limited Current Risk Indicators

Also please take a look at World Market Map. Please also try Coins and Tokens Correlation module to utilize digital token correlation table to build portfolio of cryptocurrencies across multiple exchanges.
Search macroaxis.com